{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T16:01:50Z","timestamp":1780761710157,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100010477","name":"Intuitive Surgical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010477","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1245\/s10434-026-19519-y","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:25:30Z","timestamp":1775820330000},"page":"6185-6193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perioperative Outcomes from a Phase II Study of Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Gastric Cancer and Limited Peritoneal Metastasis: ROBO-CHIP Trial"],"prefix":"10.1245","volume":"33","author":[{"given":"EeeLN","family":"Buckarma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Steadman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Mandrekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis E.","family":"Grotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"issue":"8","key":"19519_CR1","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/jso.25729","volume":"120","author":"CJ Allen","year":"2019","unstructured":"Allen CJ, Newhook TE, Vreeland TJ, et al. Yield of peritoneal cytology in staging patients with gastric and gastroesophageal cancer. J Surg Oncol. 2019;120(8):1350\u20137.","journal-title":"J Surg Oncol."},{"issue":"13","key":"19519_CR2","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1245\/s10434-016-5409-7","volume":"23","author":"N Ikoma","year":"2016","unstructured":"Ikoma N, Blum M, Chiang YJ, et al. Yield of staging laparoscopy and lavage cytology for radiologically occult peritoneal carcinomatosis of gastric cancer. Ann Surg Oncol. 2016;23(13):4332\u20137.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"19519_CR3","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1245\/s10434-017-5838-y","volume":"24","author":"N Ikoma","year":"2017","unstructured":"Ikoma N, Chen HC, Wang X, et al. Patterns of initial recurrence in gastric adenocarcinoma in the era of preoperative therapy. Ann Surg Oncol. 2017;24(9):2679\u201387.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"19519_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/jso.24087","volume":"113","author":"H Shiozaki","year":"2016","unstructured":"Shiozaki H, Elimova E, Slack RS, et al. Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases. J Surg Oncol. 2016;113(1):29\u201335.","journal-title":"J Surg Oncol."},{"issue":"6","key":"19519_CR5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/MOG.0000000000000977","volume":"39","author":"DH Ilson","year":"2023","unstructured":"Ilson DH. Advances in the treatment of gastric cancer: 2022\u20132023. Curr Opin Gastroenterol. 2023;39(6):517\u201321.","journal-title":"Curr Opin Gastroenterol."},{"issue":"7","key":"19519_CR6","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1200\/JCO.22.02331","volume":"41","author":"MA Shah","year":"2023","unstructured":"Shah MA, Kennedy EB, Alarcon-Rozas AE, et al. Immunotherapy and targeted therapy for advanced gastroesophageal cancer: ASCO Guideline. J Clin Oncol. 2023;41(7):1470\u201391.","journal-title":"J Clin Oncol."},{"key":"19519_CR7","doi-asserted-by":"crossref","unstructured":"Butensky SD, Bansal VV, Su DG et al. Consensus guideline for the management of gastric cancer with synchronous peritoneal metastases. Ann Surg Oncol. 2025.","DOI":"10.1002\/cncr.35870"},{"issue":"5","key":"19519_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.6004\/jnccn.2025.0022","volume":"23","author":"JA Ajani","year":"2025","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, et al. Gastric cancer, version 2. 2025, NCCN Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2025;23(5):169\u201391.","journal-title":"J Natl Compr Canc Netw."},{"key":"19519_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jss.2019.03.036","volume":"241","author":"AZ Paredes","year":"2019","unstructured":"Paredes AZ, Guzman-Pruneda FA, Abdel-Misih S, et al. Perioperative morbidity of gastrectomy during CRS-HIPEC: an ACS-NSQIP analysis. J Surg Res. 2019;241:31\u20139.","journal-title":"J Surg Res."},{"issue":"6","key":"19519_CR10","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","volume":"18","author":"XJ Yang","year":"2011","unstructured":"Yang XJ, Huang CQ, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18(6):1575\u201381.","journal-title":"Ann Surg Oncol."},{"issue":"23","key":"19519_CR11","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/JCO.18.01688","volume":"37","author":"PE Bonnot","year":"2019","unstructured":"Bonnot PE, Piessen G, Kepenekian V, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol. 2019;37(23):2028\u201340.","journal-title":"J Clin Oncol."},{"issue":"3","key":"19519_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jso.23633","volume":"110","author":"U Rudloff","year":"2014","unstructured":"Rudloff U, Langan RC, Mullinax JE, et al. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol. 2014;110(3):275\u201384.","journal-title":"J Surg Oncol."},{"issue":"1","key":"19519_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1245\/s10434-020-08739-5","volume":"28","author":"B Badgwell","year":"2021","unstructured":"Badgwell B, Ikoma N, Murphy MB, et al. A phase II trial of cytoreduction, gastrectomy, and hyperthermic intraperitoneal perfusion with chemotherapy for patients with gastric cancer and carcinomatosis or positive cytology. Ann Surg Oncol. 2021;28(1):258\u201364.","journal-title":"Ann Surg Oncol."},{"key":"19519_CR14","unstructured":"Services USDoHaH. Common terminology criteria for adverse events (CTCAE) Version 5.0 2017. 2025. 2017."},{"issue":"3","key":"19519_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00134-006-0478-x","volume":"33","author":"R Bellomo","year":"2007","unstructured":"Bellomo R, Kellum JA, Ronco C. Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med. 2007;33(3):409\u201313.","journal-title":"Intensive Care Med."},{"issue":"4","key":"19519_CR16","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/jso.27990","volume":"131","author":"NJ Kelly","year":"2025","unstructured":"Kelly NJ, Shafique N, Tortorello GN, et al. Total gastrectomy for gastric malignancy: trends over 15 years in major morbidity, mortality, and patient selection from the National Surgical Quality Improvement Program. J Surg Oncol. 2025;131(4):624\u20139.","journal-title":"J Surg Oncol."},{"issue":"8","key":"19519_CR17","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1245\/s10434-020-09465-8","volume":"28","author":"WJ Koemans","year":"2021","unstructured":"Koemans WJ, Houwink A, van der Kaaij RT, et al. Perioperative management of gastric cancer patients treated with (sub)total gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy (HIPEC): lessons learned. Ann Surg Oncol. 2021;28(8):4647\u201354.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"19519_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ejso.2018.01.006","volume":"44","author":"A Agnes","year":"2018","unstructured":"Agnes A, Lirosi MC, Panunzi S, et al. The prognostic role of perioperative allogeneic blood transfusions in gastric cancer patients undergoing curative resection: a systematic review and meta-analysis of non-randomized, adjusted studies. Eur J Surg Oncol. 2018;44(4):404\u201319.","journal-title":"Eur J Surg Oncol."},{"issue":"12","key":"19519_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108690","volume":"50","author":"D Edholm","year":"2024","unstructured":"Edholm D, Linder G, Hedberg J, et al. Perioperative blood transfusions associated with reduced survival in gastroesophageal cancers\u2014A Swedish population-based study. Eur J Surg Oncol. 2024;50(12):108690.","journal-title":"Eur J Surg Oncol."},{"issue":"21","key":"19519_CR20","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.3390\/cancers13215438","volume":"13","author":"FK Hsu","year":"2021","unstructured":"Hsu FK, Chang WK, Lin KJ, Liu CY, Fang WL, Chang KY. The associations between perioperative blood transfusion and long-term outcomes after stomach cancer surgery. Cancers. 2021;13(21):5438.","journal-title":"Cancers."},{"issue":"29","key":"19519_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004322","volume":"95","author":"D Reim","year":"2016","unstructured":"Reim D, Strobl AN, Buchner C, et al. Perioperative transfusion of leukocyte depleted blood products in gastric cancer patients negatively influences oncologic outcome: a retrospective propensity score weighted analysis on 610 curatively resected gastric cancer patients. Medicine (Baltimore). 2016;95(29):e4322.","journal-title":"Medicine (Baltimore)."},{"issue":"3","key":"19519_CR22","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jamcollsurg.2015.06.012","volume":"221","author":"MH Squires 3rd","year":"2015","unstructured":"Squires MH 3rd, Kooby DA, Poultsides GA, et al. Effect of perioperative transfusion on recurrence and survival after gastric cancer resection: a 7-institution analysis of 765 patients from the US Gastric Cancer Collaborative. J Am Coll Surg. 2015;221(3):767\u201377.","journal-title":"J Am Coll Surg."},{"issue":"3","key":"19519_CR23","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1245\/s10434-022-12761-0","volume":"30","author":"BL Green","year":"2023","unstructured":"Green BL, Blumenthaler AN, Gamble LA, et al. Cytoreduction and HIPEC for gastric carcinomatosis: multi-institutional analysis of two phase II clinical trials. Ann Surg Oncol. 2023;30(3):1852\u201360.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"19519_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12957-025-03749-7","volume":"23","author":"R Hayler","year":"2025","unstructured":"Hayler R, Domingos N, Ashrafizadeh A, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases at an Australian centre. World J Surg Oncol. 2025;23(1):93.","journal-title":"World J Surg Oncol."},{"issue":"8","key":"19519_CR25","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1245\/s10434-019-07450-4","volume":"26","author":"I Manzanedo","year":"2019","unstructured":"Manzanedo I, Pereira F, Rihuete Caro C, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer with peritoneal carcinomatosis: multicenter study of Spanish Group of Peritoneal Oncologic Surgery (GECOP). Ann Surg Oncol. 2019;26(8):2615\u201321.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"19519_CR26","doi-asserted-by":"publisher","first-page":"5544","DOI":"10.1245\/s10434-023-13654-6","volume":"30","author":"MG Davey","year":"2023","unstructured":"Davey MG, Temperley HC, O\u2019Sullivan NJ, et al. Minimally invasive and open gastrectomy for gastric cancer: a systematic review and network meta-analysis of randomized clinical trials. Ann Surg Oncol. 2023;30(9):5544\u201357.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"19519_CR27","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jamcollsurg.2015.01.058","volume":"220","author":"LV Selby","year":"2015","unstructured":"Selby LV, Vertosick EA, Sjoberg DD, Schattner MA, Janjigian YY, Brennan MF, Strong VE. Morbidity after total gastrectomy: analysis of 238 patients. J Am Coll Surg. 2015;220(5):863\u201371.","journal-title":"J Am Coll Surg"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19519-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19519-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19519-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:51:47Z","timestamp":1780761107000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19519-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["19519"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19519-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}